MBHB Partner Kevin Noonan Quoted in Bloomberg BNA Life Sciences Law & Industry Report Article Regarding Top 2015 Patent Issues

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted extensively in a January 9, 2015 edition of Bloomberg BNA’s Life Sciences Law & Industry Report in an article entitled, “Patents Are Back as Top Issue for 2015, Life Sciences Attorneys Say.” Bloomberg BNA’s Life Sciences Law & Industry Report asked its editorial advisory board members and other life sciences attorneys for their top issues for 2015. Patent eligibility for products of nature and diagnostic methods, the continued implementation of patent reform under the America Invents Act and patent litigation loomed large in their picks, as did the regulatory approval of biosimilars. Personalized medicine wasn’t specifically mentioned but was an underlying theme for a number of issues. View the article